The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

RIGL FINANCIAL STATEMENTS

Rigel Pharmaceuticals Inc — balance sheet, income statement and cash flow trends

RIGLRigel Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0200 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue276.8 M $Gross Profit252.9 M $ · 91%Operating Income87.1 M $ · 31%Pre-tax Income85.6 M $ · 31%Net Income to Owners321.9 M $ · 116%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue276.8 M $+3.3%
Gross Profit252.9 M $+3.2%
Operating Income87.1 M $-16.8%
EBITDA94 M $-14.0%
Net Income to Owners321.9 M $+229.1%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0200 M400 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets521.1 M
  • Equity425.4 M $82%
  • Current Liabilities95.4 M $18%
  • Long-term Liabilities58 K $0%

Key Figures

YoY change
Total Assets521.1 M $+152.0%
Total Liabilities95.4 M $-23.5%
Total Equity425.4 M $+419.2%
Cash & ST Investments95.3 M $-12.0%
Total Debt40 M $-34.6%
Net Debt-20.9 M $-373.2%

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-50 M050 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
025 M50 M75 M79.4 M $Operating-49.1 M $Investing-22.9 M $Financing7.4 M $Net Change

Key Figures

YoY change
Operating Cash Flow79.4 M $+20.6%
Capital Expenditures24 K $-33.3%
Free Cash Flow79.4 M $+20.7%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on RIGL

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 11, 26. This content is for informational purposes only and is not investment advice.